Mycophenolic Acid Mycophenolic acid exhibits immunosuppressive, antiviral, and anticancer activities. Mycophenolic acid inhibits B cell activation and decreases the number of plasmablasts in clinical subjects with systemic lupus erythmatosus (SLE).…
Myclobutanil Myclobutanil is an antifungal compound that suppresses ergosterol and fungal cell wall synthesis by inhibiting sterol 14α demethylase. Myclobutanil also weakly inhibits testosterone production in mammals. References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18946003…
Mubritinib, Free Base Mubritinib is an EGFR2 (HER2) inhibitor that underwent clinical trials, showing some promise as an anticancer chemotherapeutic in the treatment of bladder, kidney, and prostate cancer, but…
MS436 MS346 is an inhibitor of bromodomain BRD4. This compound displays anti-inflammatory activity, decreasing the production of NO and pro-inflammatory cytokines in macrophages. References PubMed ID：:http://www.ncbi.nlm.nih.gov/pubmed/18945969 Cas No. 1395084-25-9 Formula…
Moxifloxacin Hydrochloride Moxifloxacin is a fluoroquinolone antibiotic commonly used to treat ocular infections such as bacterial conjunctivitis as well as sinus and lung infections such as pneumonia. Moxifloxacin displays antibacterial…
Moxifloxacin Free Base Moxifloxacin is a fluoroquinolone antibiotic commonly used to treat ocular infections such as bacterial conjunctivitis as well as sinus and lung infections such as pneumonia. Moxifloxacin displays…
Motilin, pig Motilin is an endogenous ghrelin-related peptide hormone that modulates gastrointestinal motility and is released during fasting. Motilin binds the motilin receptor, activating cholinergic signaling that induces contractions in…
Motilin, dog Motilin is an endogenous ghrelin-related gut peptide that modulates gastrointestinal motility and is released during fasting. Motilin binds the motilin receptor, activating cholinergic signaling that induces contractions in…
Motesanib Diphosphate Motesanib is an inhibitor of VEGFR 1/2/3, PDGFR, c-Kit, and RET that displays anticancer chemotherapeutic and anti-angiogenic activities. In vivo, motesanib inhibits tumor growth of xenografts of various…
Motesanib Motesanib is an inhibitor of VEGFR 1/2/3, PDGFR, c-Kit, and RET that displays anticancer chemotherapeutic and anti-angiogenic activities. In vivo, motesanib inhibits tumor growth of xenografts of various cancers.…